Rüdiger Hehlmann
Impact in
- Hematology top 0.02%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Genetics top 0.05%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 184
- Chronic Myeloid Leukemia Treatments 166
- Acute Myeloid Leukemia Research 27
- Genetics 156
- Chronic Lymphocytic Leukemia Research 117
- Myeloproliferative Neoplasms: Diagnosis and Treatment 33
- Co-authors
- Andreas HochhausMichele BaccaraniJoerg HasfordChristine Leib‐MöschWolfgang SeifarthUte BergerNicholas C.P. CrossSusanne Saußele
- Journals
- Blood (54 papers)Leukemia (33 papers)Annals of Hematology (16 papers)Journal of Molecular Medicine (14 papers)British Journal of Haematology (12 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Rüdiger Hehlmann
270 papers receiving 11.1k citations
Hit Papers
Peers
Comparison fields: 5 of 149
- Hematology 7.9k
- Genetics 6.5k
- Rheumatology 4.0k
- Pathology and Forensic Medicine 956
- Oncology 1.2k
Countries citing papers authored by Rüdiger Hehlmann
This map shows the geographic impact of Rüdiger Hehlmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rüdiger Hehlmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rüdiger Hehlmann more than expected).
Fields of papers citing papers by Rüdiger Hehlmann
This network shows the impact of papers produced by Rüdiger Hehlmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rüdiger Hehlmann. The network helps show where Rüdiger Hehlmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Rüdiger Hehlmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 9 | |
| 3 | 2023 | 37 | |
| 4 | 2020 | 0 | |
| 5 | 2018 | 33 | |
| 6 | 2016 | 6 | |
| 7 | 2015 | 45 | |
| 8 | 2014 | 19 | |
| 9 | 2010 | 120 | |
| 10 | 2006 | 3 | |
| 11 | 2005 | 40 | |
| 12 | 2004 | 6 | |
| 13 | 2003 | 17 | |
| 14 | 2003 | 51 | |
| 15 | 2003 | 17 | |
| 16 | Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy Hit paper breakdown → | 2002 | 675 |
| 17 | 2000 | 12 | |
| 18 | 1997 | 19 | |
| 19 | Analysis and validation of prognostic factors for CML | 1996 | 23 |
| 20 | 1983 | 3 |
About Rüdiger Hehlmann
Rüdiger Hehlmann is a scholar working on Hematology, Genetics, Rheumatology, Pathology and Forensic Medicine and Oncology, having authored 284 papers that have together received 11.5k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (166 papers), Chronic Lymphocytic Leukemia Research (117 papers), Eosinophilic Disorders and Syndromes (82 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (33 papers), Lymphoma Diagnosis and Treatment (30 papers), Acute Myeloid Leukemia Research (27 papers), Acute Lymphoblastic Leukemia research (20 papers) and Chromosomal and Genetic Variations (17 papers). The work is most often cited by research in Hematology (7.9k citations), Genetics (6.5k citations), Rheumatology (4.0k citations), Pathology and Forensic Medicine (956 citations) and Oncology (1.2k citations). Rüdiger Hehlmann has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Andreas Hochhaus, Michele Baccarani, Joerg Hasford, Christine Leib‐Mösch, Wolfgang Seifarth, Ute Berger, Nicholas C.P. Cross, Susanne Saußele, Markus Pfirrmann and Claudia Schoch. Their work appears in journals such as Blood, Leukemia, Annals of Hematology, Journal of Molecular Medicine and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.